Search results for "molecular microbiology"

SARS-CoV-2 Nucleoprotein is a recombinant antigen manufactured in E. coli cells to high purity for use in vaccine research and immunoassay development. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

Professor Karen Faulds explores the biggest advantage of SERS: the ability to analyze multiple analytes in one sample

Paul Andrews, National Phenotypic Screening Centre, discusses challenges and trends in cellular modeling of disease

Meet one of the first cryo-EM groups set on delivering a resolution revolution

Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation

Designed for quantitative analysis, Waters' full portfolio of TQ MS systems makes high performance and routine analysis accessible, robust, reliable

Plans in pipeline to build a dedicated continuous bioprocessing facility in Fribourg, Switzerland, featuring Pall Life Sciences’ Cadence platform technologies

TwistDx’s proprietary technology, Recombinase Polymerase Amplification (RPA), is transforming the ability to amplify and detect nucleic acids, in laboratory and resource-limited field settings

Photometrics Prime 95B leverages backside illuminated sensor technology providing three times more sensitivity than previous scientific CMOS cameras

Promega NanoLuc Enables a First in Measuring Drug-Target Residence in Live Cells